WHO ICTRP trial

Effect of perioperative intravenous infusion of lidocaine on the postoperative…

CTIS2025-521808-22-01 · EU Clinical Trials Information System · Not Recruiting

Key facts

Trial ID CTIS2025-521808-22-01
Public title Effect of perioperative intravenous infusion of lidocaine on the postoperative course and the immune response in patients undergoing surgery for colon cancer - the PILDI study
Scientific title Effect of perioperative intravenous infusion of lidocaine on the postoperative course and the immune response in patients undergoing surgery for colon cancer - the PILDI study - ORI2025-16
Primary sponsor Institute Of Oncology Ljubljana
Registry EU Clinical Trials Information System
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No
Countries Slovenia
Conditions Colon cancer MedDRA version: 20.0Level: PTClassification code: 10009944Term: Colon cancer Class: 100000004864;Therapeutic area: Diseases [C] - Neoplasms [C04]
Interventions Product Name: SODIUM CHLORIDE, Product Code:SUB12581MIG, Pharmaceutical Form: SOLUTION FOR INFUSION, Other descriptive name: , Strength: , Pharmaceutical form of the placebo: SOLUTION FOR INFUSION , Product Name: LIDOCAINE HYDROCHLORIDE…
Registration date Jul 16, 2025
Target size 100
Secondary IDs NCT06923787
Registry page euclinicaltrials.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations